News COVID-19 bites into Pfizer’s Q3, but biopharma revenues rise Pfizer is one of the front-runners in the race to approve a COVID-19 vaccine
News COVID-19 ventilator demand fuels Philips Q3 sales Huge demand for ventilators and patient monitors spurred third quarter sales for Royal Philips, the company announced.
News GSK boosts anti-infectives pipeline with Scynexis antifungal Last year, GSK said it was planning to invest a cool £1 billion in infectious d
R&D Sponsored Trials and tribulations of drug development What does it take to establish new treatments for rare diseases?